Based on the combination of their clinical manifestations and clinical treatment efficacy, 3 patients who had elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels but stable tumors were considered likely to have died of heart failure (Table 4). This evidence concerns the gene NPPB and heart failure.